These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33547544)

  • 21. In silico screening for novel inhibitors of DNA polymerase III alpha subunit of Mycobacterium tuberculosis (MtbDnaE2, H37Rv).
    Jadaun A; Sudhakar D R; Subbarao N; Dixit A
    PLoS One; 2015; 10(3):e0119760. PubMed ID: 25811866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.
    Shah P; Saquib M; Sharma S; Husain I; Sharma SK; Singh V; Srivastava R; Shaw AK; Siddiqi MI
    Bioorg Chem; 2015 Apr; 59():91-6. PubMed ID: 25727263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression, purification, crystallization and preliminary structural study of dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD), the fourth enzyme of the dTDP-L-rhamnose synthesis pathway, from Salmonella enterica serovar Typhimurium.
    Giraud MF; McMiken HJ; Leonard GA; Messner P; Whitfield C; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 1999 Dec; 55(Pt 12):2043-6. PubMed ID: 10666586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis.
    Evans GL; Gamage SA; Bulloch EM; Baker EN; Denny WA; Lott JS
    Chembiochem; 2014 Apr; 15(6):852-64. PubMed ID: 24623674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.
    Cheng VW; Leung KS; Kwok JS; Leung RK; Yang KY; Chan RC; Kam KM; Tsui SK
    Microb Drug Resist; 2016 Oct; 22(7):545-551. PubMed ID: 27082669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.
    Chaitanya M; Babajan B; Anuradha CM; Naveen M; Rajasekhar C; Madhusudana P; Kumar CS
    J Mol Model; 2010 Aug; 16(8):1357-67. PubMed ID: 20140471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of new
    Mehra R; Chib R; Munagala G; Yempalla KR; Khan IA; Singh PP; Khan FG; Nargotra A
    Mol Divers; 2015 Nov; 19(4):1003-19. PubMed ID: 26232029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
    Tripathi A; Wadia N; Bindal D; Jana T
    Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies.
    Punkvang A; Hannongbua S; Saparpakorn P; Pungpo P
    J Biomol Struct Dyn; 2016 May; 34(5):1079-91. PubMed ID: 26156406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor binding studies of
    Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
    Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
    PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
    Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
    PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors.
    Chauhan D; George G; Sridhar SNC; Bhatia R; Paul AT; Monga V
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900029. PubMed ID: 31407389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation on a theme of SDR. dTDP-6-deoxy-L- lyxo-4-hexulose reductase (RmlD) shows a new Mg2+-dependent dimerization mode.
    Blankenfeldt W; Kerr ID; Giraud MF; McMiken HJ; Leonard G; Whitfield C; Messner P; Graninger M; Naismith JH
    Structure; 2002 Jun; 10(6):773-86. PubMed ID: 12057193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.